The inexorable rise in the UK NHS drugs bill: Recent policies, future prospects

Public Administration

Volumn 74, Issue 3, 1996, Pages 393-411

  Earl Slater, Alan ^a   Bradley, Colin ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012829692     PISSN: 00333298     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-9299.1996.tb00877.x     Document Type: Article

References (58)

1. Abel-Smith, B. 1994. An introduction to health policy, planning and financing. London: Longman.
2. ABPI. 1993. The prescribing paradox. London: ABPI.
3. ACST. 1993. A report on medical research and health. Advisory Council on Science and Technology. London: HMSO.
4. Arber, S. 1987. 'Social class, non-employment and chronic illness,' British Medical Journal 294, 1069-76.
5. Audit Commission. 1994. A prescription for improvement. London: HMSO.
6. Barr, N. 1994. Economics of the welfare state. 2nd edn. London: Weidenfeld and Nicolson.
7. Bishop, M., J. Kay, and C. Mayer. 1995. The regulatory challenge. Oxford: Oxford University Press.
8. Blenkinsopp, A. and C. Bradley. 1996. 'Patients, society, and the increase in self-medication.' British Medical Journal 312, 629-32.
9. Bloor, K. and A. Maynard. 1993. 'Expenditure on the NHS during and after the Thatcher years: its growth and utilisation.' University of York: CHE working paper.
10. Bradley, C.P. 1991. 'Decision-making and prescribing patterns,' Family Practice 8, 3, 276-87.
11. Bradlow, J. and A. Coulter. 1993. 'Effect of fundholding and indicative prescribing schemes on general practitioners' referral patterns,' British Medical Journal 306, 433-7.
12. Cohen Committee. 1953. Joint Committee on Prescribing: final report. London: HMSO.
13. Colin-Thomé, D. 1996. 'The total fundholder,' in G. Meads (ed.) (see below).
14. Coulter, A. 1995. 'Evaluating general practice fundholding in the United Kingdom,' European Journal of Public Health 5, 233-9.
15. Craig, A-M., M. Malek, and P. Beardon. 1993. 'The main influences of doctor prescribing behaviour and the role of pharmaceutical company promotional activity,' in M. Malek, P. Vacani, J. Rasquinha and P. Davey (eds.), Managerial issues in the reformed NHS. London: John Wiley and Sons.
16. Currie, C.J., M.D.R. Brownlee and J.R. Peters. 1995. 'Trends in the prescribing of drugs for cardiovascular disease in Wales,' British Journal of Medical Economics 8, 171-9.
17. Department of Health. 1987. Primary health care. White Paper. London: HMSO.
18. _. 1989. Working for patients. White Paper. London: HMSO.
19. Earl-Slater, A. 1996a. 'The impact of advertising expenditure on the drugs bill,' Pharmaceutial Marketing, forthcoming.
20. _. 1996b. 'Recent developments in regulating the pharmaceutical business in the EU,' European Business Review, 96, 1, 17-25.
21. Feely, M.P. 1996. 'Generic prescribing,' in C. Harris (ed.) (see below).
22. Ferguson, J. 1996. 'PACT', in C. Harris (ed.) (see below).
23. Gidar, R.S. 1996. 'Community pharmacists,' in C. Harris (ed.) (see below).
24. Greenfield. 1982. Report to the secretary of state of the informal working group on effective prescribing. London: HMSO.
25. Griffin, J. (ed.). 1992. Medicines: regulation, research and risk. 2nd edn. Belfast: The Queens University Press.
26. Ham, C. 1996. 'Managed markets in health care: the UK experiment,' Health Policy 35, 279-92.
27. Hancher, L. 1990. Regulating for competition. Oxford: Clarendon Press.
28. Harris, C. 1994. 'Better feedback on prescribing,' The British Medical Journal 309, 356.
29. _. (ed.). 1996. Prescribing in general practice. Oxford: Radcliffe Medical Publications.
30. Health Committee. 1994. Priority setting in the NHS: the NHS drugs budget. 2nd Report. London: HMSO.
31. House of Commons Social Services Select Committee. 1989. Final report on the NHS White Paper reforms. 10 August. London: HMSO.
32. Hughes, D. and A. McGuire. 1995. 'Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration approach,' Health Economics 4, 3, 213-21.
33. Jolleys, J.V. 1996. 'Audit,' in C. Harris (ed.) (see above).
34. Lavers, R. 1989. 'Prescription charges, the demand for prescriptions and morbidity.' Applied Economics 21, 1043-52.
35. Meads, G. (ed.). 1996. Future options for general practice. Oxford: Radcliffe Medical Press.
36. Mills, G. and A. Chaffe. 1993. 'Is cost-awareness really improving?' Health Trends 25, 1, 38-48.
37. MILPRO. 1993. 'Doctors oppose limited care,' in Rationing Medicine. London: ABPI.
38. Malone, G. 1996. Hansard written reply, 5 March, cols. 189-190. Vol 273. London: HMSO.
39. Mooney, G. 1994. Key issues in health economics. London: Harvester Wheatsheaf.
40. NAO. 1993. Repeat prescribing by general medical practitioners. London: National Audit Office.
41. O'Brien, B. 1982. 'Taxing the sick,' Times Health Supplement 19 Jan.
42. OHE. 1993. The impact of unemployment on health. London: Office of Health Economics.
43. Pietroni, P. 1996. 'The integrated community care practice: general practice, citizenship and community care,' in G. Meads (see above)
44. POST. 1993. Technology and the NHS Drugs Bill Technical Report. London: Parliamentary Office of Science and Technology (POST).
45. PPRS report. 1996. The pharmaceutical price regulation scheme. Report to Parliament. International and Industry Division, DOH. London: DOH.
46. Ranadé, W. 1995. 'The theory and practice of managed competition in the National Health Service,' Public Administration 73, 2, 241-62.
47. Reilly, A., D. Brown, R.J. Taylor, and J. Webster. 1986. 'Effect of limited list on drug use,' The Phamaceutical Journal 19 April, 480-2.
48. Reilly, P.M. 1996. 'Formularies,' in C. Harris (ed.). (see above).
49. Ryan, M. and S. Birch. 1989. 'Charging for health care: evidence on the utilisation of NHS prescribed drugs,' Social Science and Medicine 33, 681-7.
50. Ryan, M., B. Yule, C. Bond, and R. Taylor. 1992. 'Knowledge of drug costs,' British Journal of General Practice 42, 6-9.
51. Sargent, J. A. 1985. The politics of the pharmaceutical price regulation scheme, pp. 105-27 in W. Streek and P.C. Schmitter (eds.), Private interest government: beyond market and state. Sage series in neo-corporatism. Beverly Hills, Calif.: Sage publications.
52. Seator, D.J.D. 1996. 'Prescribing advisors and budgets,' in C. Harris (ed.) (see above).
53. Smith, S. and S. Watson. 1990. 'Modelling the effect of prescription charge rises,' Fiscal Studies 11, 75-95.
54. Storey, N. 1996. 'The primary care trust: coordination for cohesion,' in G. Meads (ed.) (see above).
55. The Agreement. DOH. 1993. Pharmaceutical price regulation scheme. Department of Health, Scottish Home and Health Department, Department of Health and Social Services Northern Ireland, the Welsh Office and the Association of the British Pharmaceutical Industry. London: HMSO.
56. Thomas, D.H. and P.R. Noyce. 1996. 'The interface between self-medication and the NHS,' British Medical Journal 312, 688-91.
57. Vickers, J. 1994. Concepts of Competition. Oxford: Oxford University Press.
58. Zermansky, A. 1996. 'Repeat prescribing,' in C. Harris (ed.) (see above).